Previously we described an interleukin-23 (IL-23)-granulocyte macrophage colony-stimulating factor (GM-CSF) axis as a key driver of dysregulated hematopoiesis in colitis (Griseri et al., 2012); however, the relative contribution of distinct innate effector cells downstream of this pathway remains unknown. The gene discussed is CSF2; the disease is colitis.